Kobayashi T, Iwama S, Yamagami A, Yasuda Y, et al. Elevated TSH level, TgAb and prior use of ramucirumab or TKIs as risk factors for thyroid dysfunction in PD-L1 blockade. J Clin Endocrinol Metab 2022 Aug 3. pii: 6653516. doi: 10.1210.
PMID: 35918067